Cargando…
Kidney Allograft Monitoring by Combining Donor-Derived Cell-Free DNA and Molecular Gene Expression: A Clinical Management Perspective
Donor-derived cell-free DNA (dd-cfDNA) may safely assess kidney allograft rejection. Molecular Microscope (MMDx(®)) gene expression may offer increased precision to histology. This single-center retrospective study monitored kidney transplant recipients for rejection at specified time intervals by u...
Autores principales: | Rizvi, Asim, Faiz, Sara, Thakkar, Parin H., Hussain, Syed, Gamilla-Crudo, Ann N., Kueht, Michael, Mujtaba, Muhammad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455393/ https://www.ncbi.nlm.nih.gov/pubmed/37623456 http://dx.doi.org/10.3390/jpm13081205 |
Ejemplares similares
-
Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients
por: Kueht, Michael, et al.
Publicado: (2022) -
The Current State of Donor-Derived Cell-Free DNA Use in Allograft Monitoring in Kidney Transplantation
por: Kueht, Michael L., et al.
Publicado: (2022) -
Differing Tales of Two Patients after Receiving a Kidney Transplant from a Donor with Disseminated Intravascular Coagulation
por: Kadambi, Pradeep V., et al.
Publicado: (2014) -
Multisite biologic tissue SARS-CoV-2 PCR testing in kidney transplantation from a COVID-positive donor
por: Zhang, Jared R, et al.
Publicado: (2022) -
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2023)